Promoter Docon sells 5.33 million Thyrocare shares, about 10% stake

Promoter Stake Sell 1pctOwnership Changes View source PDF Explain this filing

THYROCARE · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

+1.6%Reaction day

₹416.70

prior close

₹423.20

announcement price

In-mkt

timing

Nifty Microcap 250market · index membership as recorded later (tracked since Jun 2026)-0.3%+1.9% vs market

Healthcare Service Provider peers, median of 22sector+0.1%+1.4% vs sector

On the reaction day the stock moved 1.9 pts more than Nifty Microcap 250 and 1.4 pts more than its Healthcare Service Provider peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

+0.0

10m

+0.2

15m

+0.2

30m

+0.4

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

+1.6-0.3+1.9+0.1+1.4

Next day

+3.1+0.1+3.1+1.2+1.9

+6.4+0.3+6.1+0.2+6.2

+8.0+0.8+7.2+0.3+7.7

+8.1+0.6+7.5-1.5+9.5

+10.2+0.2+10.0-1.7+12.0

+8.1+0.5+7.6-1.1+9.2

15d

+24.4-0.1+24.5-2.0+26.4

+17.9-3.5+21.4-0.9+18.8

+8.7-5.0+13.8-8.5+17.2

+9.3-13.4+22.7-9.8+19.1

UpDownMarket · Nifty Microcap 250Sector · Healthcare Service Provider peers, median of 22Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

On October 24, 2025, promoter Docon Technologies sold 5,332,860 Thyrocare shares through market trades for Rs 667.69 crore, at an average price of Rs 1,252.03 per share. The shares represent about 10% of the company. Promoter holding fell from 70.98% to 60.93%, and Docon remains a promoter.

Likely market impact

The 10% promoter sell-down may create near-term selling pressure, though promoters still hold 60.93% and retain control.